0001085146-23-004322.txt : 20231113
0001085146-23-004322.hdr.sgml : 20231113
20231113170350
ACCESSION NUMBER: 0001085146-23-004322
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230930
FILED AS OF DATE: 20231113
DATE AS OF CHANGE: 20231113
EFFECTIVENESS DATE: 20231113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHI Advisors LLC
CENTRAL INDEX KEY: 0001791468
IRS NUMBER: 141874283
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1230
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-19612
FILM NUMBER: 231399900
BUSINESS ADDRESS:
STREET 1: 599 LEXINGTON AVENUE
STREET 2: 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 2122014829
MAIL ADDRESS:
STREET 1: 599 LEXINGTON AVENUE
STREET 2: 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0001791468
XXXXXXXX
09-30-2023
09-30-2023
false
CHI Advisors LLC
599 Lexington Avenue
20th Floor
NEW YORK
NY
10022
13F HOLDINGS REPORT
028-19612
000304684
801-117253
Y
Cowen Investment Management LLC and its affiliates ("Cowen") may be deemed to be ultimately controlled by Toronto-Dominion Bank and its affiliates ("TD"), by virtue of their corporate relationship. Neither TD nor Cowen share information with one another related to their investments, with certain exceptions. However, under Section 13(f) of the Securities Exchange Act 1934, as amended, and the rules promulgated thereunder, TD may be deemed to have shared investment discretion with Cowen over the securities managed by Cowen.
Ashley Latourelle
Chief Compliance Officer
(609) 304-6161
/s/ Ashley Latourelle
New York
NY
11-13-2023
0
28
252306335
false
INFORMATION TABLE
2
infotable.xml
INFORMATION TABLE
2SEVENTY BIO INC
COMMON STOCK
901384107
BBG00YV1J631
3927867
1002007
SH
DFND
6
1002007
0
0
ACELYRIN INC
COM
00445A100
23014608
2262990
SH
DFND
6
2262990
0
0
BLACK DIAMOND THERAPEUTICS I
COM
09203E105
BBG00MS4Y0X8
2066400
720000
SH
DFND
6
720000
0
0
BLUEPRINT MEDICINES CORP
COM
09627Y109
BBG001V11BV0
4664835
92888
SH
DFND
6
92888
0
0
COMPASS THERAPEUTICS INC
COM
20454B104
BBG00LPXKF34
5574532
2829712
SH
DFND
6
2829712
0
0
CULLINAN ONCOLOGY INC
COM
230031106
BBG00HW2DGR3
30898410
3414189
SH
DFND
6
3414189
0
0
DIREXION SHS ETF TR
DAILY S&P BIOTEC
25460G716
BBG0099SHGK3
4635000
225000
SH
DFND
6
225000
0
0
DISC MEDICINE INC
COM
254604101
BBG00W9MJL04
1174500
25000
SH
DFND
6
25000
0
0
FREELINE THERAPEUTICS HLDGS
SPONSORED ADS
35655L206
372613
86654
SH
DFND
6
86654
0
0
GRAPHITE BIO INC
COM
38870X104
BBG00XDH4P05
572726
230938
SH
DFND
6
230938
0
0
IKENA ONCOLOGY INC
COM
45175G108
BBG00XZY4TH8
9443445
2180934
SH
DFND
6
2180934
0
0
INOZYME PHARMA INC
COM
45790W108
BBG00J7QJMD0
5334112
1270027
SH
DFND
6
1270027
0
0
KEROS THERAPEUTICS INC
COM
492327101
BBG00H1HP9H8
12995340
407633
SH
DFND
6
407633
0
0
LARIMAR THERAPEUTICS INC
COM
517125100
BBG001V0GD97
13487148
3414468
SH
DFND
6
3414468
0
0
MINERALYS THERAPEUTICS INC
COM
603170101
BBG00ZXN1GR9
5405284
568379
SH
DFND
6
568379
0
0
MOONLAKE IMMUNOTHERAPEUTICS
CLASS A ORD
61559X104
BBG00XQZQVP7
3420000
60000
SH
DFND
6
60000
0
0
OMEGA THERAPEUTICS INC
COMMON STOCK
68217N105
BBG00WCNQZQ1
2270146
1055882
SH
DFND
6
1055882
0
0
ORCHARD THERAPEUTICS PLC
SPON ADS NEW
68570P200
14034773
12315654
SH
DFND
6
12315654
0
0
OVID THERAPEUTICS INC
COM
690469101
BBG009F0TD85
3320916
864822
SH
DFND
6
864822
0
0
PLIANT THERAPEUTICS INC
COM
729139105
BBG00C8083P2
52266211
3014199
SH
DFND
6
3014199
0
0
PLIANT THERAPEUTICS INC
COM
729139105
BBG00C8083P2
55000
137500
SH
Call
DFND
6
137500
0
0
PRECISION BIOSCIENCES INC
COM
74019P108
BBG008NSBPW2
207043
606629
SH
DFND
6
606629
0
0
RALLYBIO CORP
COM
75120L100
BBG011PFKG07
1316774
390734
SH
DFND
6
390734
0
0
REPARE THERAPEUTICS INC
COM
760273102
BBG00V5N3XG2
35837422
2966674
SH
DFND
6
2966674
0
0
REPARE THERAPEUTICS INC
COM
760273102
BBG00V5N3XG2
157500
50000
SH
Call
DFND
6
50000
0
0
SAGIMET BIOSCIENCES INC
COM SER A
786700104
BBG0020584Z8
3069810
348842
SH
DFND
6
348842
0
0
SYROS PHARMACEUTICALS INC
COM NEW
87184Q206
5119170
1299359
SH
DFND
6
1299359
0
0
ULTRAGENYX PHARMACEUTICAL IN
COM
90400D108
BBG001V2MJJ2
7664750
215000
SH
DFND
6
215000
0
0